2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Similar documents
Measure #12 (NQF 0086): Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation National Quality Strategy Domain: Effective Clinical Care

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

DENOMINATOR: All female patients aged 65 years and older with a diagnosis of urinary incontinence

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Measure #41: Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older National Quality Strategy Domain: Effective Clinical Care

Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

Measure #145: Radiology: Exposure Time Reported for Procedures Using Fluoroscopy National Quality Strategy Domain: Patient Safety

Measure #430: Prevention of Post-Operative Nausea and Vomiting (PONV) Combination Therapy National Quality Strategy Domain: Patient Safety

Measure #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Measure #112 (NQF 2372): Breast Cancer Screening National Quality Strategy Domain: Effective Clinical Care

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Measure #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

Physician Quality Reporting System (PQRS)

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

Measure #130 (NQF 0419): Documentation of Current Medications in the Medical Record National Quality Strategy Domain: Patient Safety

Measure #370 (NQF 0710): Depression Remission at Twelve Months National Quality Strategy Domain: Effective Clinical Care

Measure #420: Varicose Vein Treatment with Saphenous Ablation: Outcome Survey National Quality Strategy Domain: Effective Clinical Care

CPT only copyright 2014 American Medical Association. All rights reserved. 10/10/2014 Page 537 of 593

Measure #1 (NQF 0059): Diabetes: Hemoglobin A1c Poor Control National Quality Strategy Domain: Effective Clinical Care

THIS IS AN OFFICIAL NH DHHS HEALTH ALERT

State of Louisiana Department of Health & Hospitals Office of Public Health

The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011

Benefits Collaborative Policy Statement WOMEN S HEALTH SERVICES

2016 Physician Quality Reporting System (PQRS) Measure Specification and Measure Flow Guide for Claims and Registry Reporting of Individual Measures

Outpatient/Ambulatory Health Services

AvMed s Physician-to- Physician Referral Program

The Centers for Medicare & Medicaid Services (CMS) seeks stakeholder comments on the following clinical quality measure under development:

Coding and Billing. Commonly Asked Questions. Physician Office Reimbursement Guideline Q1. A1. Q2. A2.

Preparing for the Conversion from ICD-9 to ICD-10: What You Need to Be Doing Today

The Impact of the ACA and USPSTF Grade Change on Coverage of HIV Testing

HIV/AIDS Care: The Diagnosis Code Series 2. Prepared By: Stacey L. Murphy, MPA, RHIA, CPC AHIMA Approved ICD-10-CM/ICD-10-CM Trainer

Meaningful use. Meaningful data. Meaningful care. The 3M Healthcare Data Dictionary: Standardizing lab data to LOINC for meaningful use

Meaningful use. Meaningful data. Meaningful care. The 3M Healthcare Data Dictionary: Enabling effective health information exchange

Anthem Workers Compensation

Welcome to the Data Analytics Toolkit PowerPoint presentation on clinical quality measures, meaningful use, and data analytics.

New Brunswick Health Indicators

Understanding how to use the Quality Measure Step by Step Documents

MBS items (10994, 10995) for Pap smears and Preventive Checks taken by a Practice Nurse on behalf of a GP

Meaningful Use Reporting Quick Reference

Routine Preventive Services. Covered by Medicare 2012

Procedure Code(s): n/a This counseling service is included in a preventive care wellness examination or focused E&M visit.

Effective Integration of STI & HIV Prevention Programs

Evaluation of Geo-Social Networking Application Use Among Young Adults

Transitioning from ICD-9-CM to ICD-10-CM. Tidewater Physicians Multispecialty Group Williamsburg, VA

New Patient Visit. UnitedHealthcare Medicare Reimbursement Policy Committee

Leader's Resource. Note: Both men and women can have an STD without physical symptoms.

Reporting Audiology Quality Measures: A Step-by-Step Guide

Re: Medicare and Medicaid Programs; Electronic Health Record Incentive Program Stage 2

Consent Forms. The UltraWellness Center YOUR KEY TO LIFELONG HEALTH AND VITALITY

ICD-10-CM Training Module for Dental Practitioners. Presented by Workgroup for Electronic Data Interchange

Coding and Billing for HIV Services in Healthcare Facilities

2. For all clinical trials, the coverage analysis will also be audited to ensure compliance with the Medicare National Coverage Determination.

Title: Coding Documentation for IHS Affiliated Physician Practices

How to Approach a Study: Concepts, Hypotheses, and Theoretical Frameworks. Lynda Burton, ScD Johns Hopkins University

TEST INSTRUCTIONS FOR CROSS VENDOR EXCHANGE TABLE OF CONTENTS

Core Set of Children s Health Care Quality Measures for Medicaid and CHIP (Child Core Set)

Physical Therapy (PT) Modalities and Evaluation

INTRODUCTION: CPT CODES & ICD-9 CODES

Physician Quality Reporting System (PQRS)

2014 Naughty or Nice STD/HIV Testing Campaign Hamilton County Public Health

Meaningful Use Stage 2 Certification: A Guide for EHR Product Managers

Remote Access Technologies/Telehealth Services Medicare Effective January 1, 2016

How To Qualify For EHR Stimulus Funds Under

There s an App for That: An Innovative Tablet-Based Sexual Health Application. Ashley Scarborough, MPH Linda Creegan MS, FNP

Medical Association of Billers

Medicare and Medicaid Programs; EHR Incentive Programs

MEANINGFUL USE STAGE 2 Summary of Proposed Rule (EP)

Chlamydia THE FACTS. How do people get Chlamydia?

HEALTH INSURANCE ENROLLMENT FORM

Cleveland Department of Public Health Office of HIV/AIDS Services 75 Erieview Place Cleveland, OH 44114

Therefore, a physician should only bill for new patient services when the elements of the definition is met.


1. How are you using health IT enabled clinical quality measures for internal quality improvement efforts and patients care?

Developed by: California Department of Public Health (CDPH) Sexually Transmitted Diseases (STD) Control Branch. In collaboration with:

EXECUTIVE SUMMARY: INTEGRATED EPIDEMIOLOGIC PROFILE FOR HIV/AIDS PREVENTION AND CARE ELIGIBLE METROPOLITAN AREA PLANNING, PHILADELPHIA

GAO INDIAN HEALTH SERVICE. HIV/AIDS Prevention and Treatment Services for American Indians and Alaska Natives. Report to Congressional Requesters

California Guidelines for STD Screening and Treatment in Pregnancy

Appropriate Treatment for Children with Upper Respiratory Infection

Sexually Transmitted Infections (STIs) and the STI Clinic

Preventive Care Guideline for Asymptomatic Elderly Patients Age 65 and Over

Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

Eligible Professionals please see the document: MEDITECH Prepares You for Stage 2 of Meaningful Use: Eligible Professionals.

Health Profile for St. Louis City

National Council for Behavioral Health

Program Performance Indicators Revised Baseline & Target Setting Form January 1 June 30, 2004 Interim Progress Report

MANAGING HERPES. Living and loving with hsv. American Social Health association. by Charles Ebel & Anna Wald, M.D., M.P.H.

Preventive Services for Pregnancy SERVICE WHAT IS COVERED INTERVALS OF COVERAGE Anemia Screening Screening Annual screening for pregnant women

Assessment of Sexual Healthcare in Maryland Safety Net Providers Sites: Creation of the Sexual Health Integration Network

FAQs on Billing for Health and Behavior Services

Change is Coming in 2014! ICD-10 will replace ICD-9 for Diagnosis Coding

Preventive Care Coverage Wondering what preventive care your plan covers?

FULL ANALYSIS I. SUBSTANTIVE ANALYSIS

Meaningful Use - HL7 Version 2

Transcription:

Measure #205 (NQF 0409): HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION: Percentage of patients aged 13 years and older with a diagnosis of HIV/AIDS for whom chlamydia, gonorrhea, and syphilis screenings were performed at least once since the diagnosis of HIV infection INSTRUCTIONS: This measure is to be reported a minimum of once per reporting period for patients with HIV/AIDS seen during the reporting period. Only patients who had at least two visits during the reporting period, with at least 90 days between each visit will be counted in the denominator for this measure. This measure is intended to reflect the quality of services provided for the primary management of patients with HIV/AIDS. Measure Reporting via Registry: ICD-10-CM diagnosis codes, CPT or HCPCS codes, and patient demographics are used to identify patients who are included in the measure s denominator. The listed numerator options are used to report the numerator of the measure. The quality-data codes listed do not need to be submitted for registry-based submissions; however, these codes may be submitted for those registries that utilize claims data. DENOMINATOR: Patients aged 13 and older with a diagnosis of HIV/AIDS who had at least two medical visits during the measurement year, with at least 90 days between each visit Denominator Criteria (Eligible Cases): Patients aged 13 years of age on date of encounter AND Diagnosis for HIV/AIDS (ICD-10-CM): Z21, B20 AND Patient encounters during the reporting period (CPT or HCPCS): 99201, 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215, G0402 AND At Least Two Denominator Eligible Encounters During the Measurement Year, With at Least 90 days Between Each NUMERATOR: Patients with chlamydia, gonorrhea, and syphilis screenings performed at least once since the diagnosis of HIV infection NUMERATOR NOTE: Report G9228 when results are documented for all of the 3 screenings OR Numerator Options: Performance Met: Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings) (G9228) 11/17/2015 Page 1 of 6

OR Other Performance Exclusion: Performance Not Met: Chlamydia, gonorrhea, and syphilis screening results not documented (Patient refusal is the only allowed exclusion) (G9229) Chlamydia, gonorrhea, and syphilis screening results not documented as performed, reason not given (G9230) RATIONALE: Sexually transmitted diseases that cause mucosal inflammation (such as gonorrhea and chlamydia) increase the risk for HIV-infection (as these diseases and other sexually transmitted diseases can increase the infectiousness of and a person s susceptibility to HIV) (Galvin, 2004). CLINICAL RECOMMENDATION STATEMENTS: All patients should be screened with laboratory tests for STDs at the initial encounter (A-II for syphilis, for trichomoniasis in women, and for chlamydial infection in women aged less than 25 years; B-II for gonorrhea and chlamydial infection in all men and women), and thereafter, depending on reported high-risk behavior, the presence of other STDs, and the prevalence of STDs in the community (B-III). (Aberg, 2004) Consideration should be given to screening all HIV-infected men and women for gonorrhea and chlamydial infections. However, because of the cost of screening and the variability of prevalence of these infections, decisions about routine screening for these infections should be based on epidemiologic factors (including prevalence of infection in the community or the population being served), availability of tests, and cost. (Some HIV specialists also recommend type-specific serologic testing for herpes simplex virus type 2 for both men and women.) (B-II, for identifying STDs) (CDC, HRSA, NIH, HIVMA of IDSA, 2003) COPYRIGHT: Physician Performance Measures (Measures) and related data specifications, developed by the American Medical Association (AMA)-convened Physician Consortium for Performance Improvement (PCPI ) and the National Committee for Quality Assurance (NCQA) pursuant to government sponsorship under subcontract 6205-05-054 with Mathematica Policy Research, Inc. under contract 500-00-0033 with Centers for Medicare & Medicaid Services. These performance Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, eg, use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and the AMA, (on behalf of the PCPI) or NCQA. Neither the AMA, NCQA, PCPI nor its members shall be responsible for any use of the Measures. THE MEASURES AND SPECIFICATIONS ARE PROVIDED AS IS WITHOUT WARRANTY OF ANY KIND. 2004-6 American Medical Association and National Committee for Quality Assurance. All Rights Reserved. Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, NCQA, the PCPI and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT ) or other coding contained in the specifications. CPT contained in the Measures specifications is copyright 2004-2015 American Medical Association. G codes and associated descriptions included in these Measure specifications are in the public domain. 11/17/2015 Page 2 of 6

LOINC copyright 2004-2015 Regenstrief Institute, Inc. SNOMED CLINICAL TERMS (SNOMED CT ) copyright 2004-2015 International Health Terminology Standards Development Organization. All Rights Reserved. Use of SNOMED CT is only authorized within the United States. 11/17/2015 Page 3 of 6

11/17/2015 Page 4 of 6

2016 Registry Individual Measure Flow PQRS #205 NQF #0409: HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis Please refer to the specific section of the Measure Specification to identify the denominator and numerator information for use in reporting this Individual Measure. 1. Start with Denominator 2. Check Patient Age: a. If the Age is greater than or equal to 13 years of age at Date of Service and equals No during the measurement period, do not include in Eligible Patient Population. Stop Processing. b. If the Age is greater than or equal to 13 years of age at Date of Service and equals Yes during the measurement period, proceed to check Patient Diagnosis. 3. Check Patient Diagnosis: a. If Diagnosis for HIV/AIDS as Listed in the Denominator equals No, do not include in Eligible Patient Population. Stop Processing. b. If Diagnosis for HIV/AIDS as Listed in the Denominator equals Yes, proceed to check Encounter Performed. 4. Check Encounter Performed: a. If Encounter as Listed in the Denominator equals No, do not include in Eligible Patient Population. Stop Processing. b. If Encounter as Listed in the Denominator equals Yes, proceed to check At Least Two Denominator Eligible Encounters During the Reporting Period, With at Least 90 Days Between Each. 5. Check At Least Two Denominator Eligible Encounters During the Reporting Period, With at Least 90 Days Between Each: a. If At Least Two Denominator Eligible Encounters During the Reporting Period, With at Least 90 Days Between Each equals No, do not include in Eligible Patient Population. Stop Processing. b. If At Least Two Denominator Eligible Encounters During the Reporting Period, With at Least 90 Days Between Each equals Yes, include in the Eligible Population. 6. Denominator Population: a. Denominator population is all Eligible Patients in the denominator. Denominator is represented as Denominator in the Sample Calculation listed at the end of this document. Letter d equals 8 patients in the sample calculation. 7. Start Numerator 8. Check Chlamydia, Gonorrhea and Syphilis Screenings Documented as Performed: a. If Chlamydia, Gonorrhea and Syphilis Screening Results Documented equals Yes, include in Reporting Met and Performance Met. 11/17/2015 Page 5 of 6

b. Reporting Met and Performance Met letter is represented in the Reporting Rate and Performance Rate in the Sample Calculation listed at the end of this document. Letter a equals 4 patients in Sample Calculation. c. If Chlamydia, Gonorrhea and Syphilis Screening Results Documented as Performed equals No, proceed to Chlamydia, Gonorrhea and Syphilis Screening Results Not Documented, Due to Patient Refusal. 9. Check Chlamydia, Gonorrhea and Syphilis Screening Results Not Documented, Due to Patient Refusal: a. If Chlamydia, Gonorrhea and Syphilis Screening Results Not Documented, Due to Patient Refusal equals Yes, include in Reporting Met and Performance Exclusion. b. Reporting Met and Performance Exclusion letter is represented in the Reporting Rate and Performance Rate in the Sample Calculation listed at the end of this document. Letter b equals 2 patients in the Sample Calculation. c. If Chlamydia, Gonorrhea and Syphilis Screening Results Not Documented, Due to Patient Refusal equals No, proceed to Check Chlamydia, Gonorrhea and Syphilis Screening Results Not Documented as Performed, Reason Not Given. 10. Check Chlamydia, Gonorrhea and Syphilis Screening Results Not Documented as Performed, Reason Not Given: a. If Chlamydia, Gonorrhea and Syphilis Screening Results Not Documented as Performed, Reason Not Given equals Yes, include in Reporting Met and Performance Not Met. b. Reporting Met and Performance Not Met letter is represented in the Reporting Rate and Performance Rate in the Sample Calculation listed at the end of this document. Letter c equals 1 patient in the Sample Calculation. c. If Chlamydia, Gonorrhea and Syphilis Screening Results Not Documented as Performed, Reason Not Given equals No, proceed to Reporting not Met 11. Check Reporting Not Met: a. If Reporting Not Met equals No, Quality Data Code or equivalent not reported. 1 patient has been subtracted from the reporting numerator in the sample calculation. 11/17/2015 Page 6 of 6